Digoxin causes a l)rompt and considerable Bater and salt diuresis in congestive heart failure. This imay occur with little or no change in renal hemodynamics, but usually is associated with decreased venous pressure. At times, increased glomerular filtration rate may contribute to the diuresis. In patients with noncardiac edema and without edema, Digoxin may also initiate a slight but definite sodium diuresis. This effect is not as great as in patients with congestive heart failure and apparently is not associated with changes in renal hemodynamics, cardiac output or venous pressure.
T HE DIURETIC properties of digitalis originally described by Withering are, according to present day concepts, considered secondary to a cardiac action. Thus, the dramatic diuresis following its use in congestive heart failure is supposedly due to an increased cardiac output which in turn improves renal function.' Some believe that the primary action of digitalis is vasodilatation.2 According to this hypothesis, the drop in venous pressure in congestive heart failure following the administration of digitalis is due to dilatation of the large veins. Recent observations in the dog3 that increased renal venous pressure decreases urine flow and sodium excretion suggest that some of the diuretic effects of digitalis may be due to its vasodilatory action. Finally, the possibility remains that the drug has an action directly on the renal tubules.
Tlhe present study was undertaken to determine the acute effects of intravenously administered Digoxin on renal hemodynamics and electrolyte and water excretion in congestive heart failure. In addition, its effects on these functions in normal subjects and in patients with edema due to nephrosis and eirrhosis of the liver were observed.
In certain experiments central hemodynam-From The Department of Medicine, New York University College of Medicine, and Bellevue Hospiital, New York City, N. Y. This work has been supported by grants from the Life Insurance Medical Research Fund and the New York Heart Association. 378 ics and pressures were also measured.4 These studies were undertaken in part to determine the sequence of events following the administration of the drug. It soon became apparent, however, that the changes induced by intravenous Digoxin were too rapid to permit definite conclusions on this point. Nevertheless, the data delimit to some degree the mode of action of Digoxin.
MATERIALS AND METHODS
A. Patient Material. The effect of Digoxin administered intravenously was examined in 10 patients who exhibited one or more signs of congestive heart failure (table 1). The patients either had ieceived no digitalis previously or had been off the drug long enough to minimize the danger of the intravenous glycoside. One patient receiveed Digoxin during three different bouts of failure. Although all drug therapy had beeen withheld, some diuresis coincident with bed rest occurred in several of the patients prior to the time of study. The severity of congestive heart failure at the time of stu(dy varied from mild to severe (table 1) .
Six of the patients had hypertensixe ando,/'o arteriosclerotic heart disease, 1 had probable rheumatic heart disease and 3 had heart disease of unkinows etiology. The congestive heart failure inl patient I was complicated by acute glomnerulonephritis and in patient 7 by a severe anemnia and hlvp-Iolproteinemia due to gastrointestinal malignancy (table 1) .
The group without cardiac disease includedl5 ciirhotic patients with ascites, 2 patients with nephrotic edema, and 28 patients wsith no cardiac or rcalil disease and no edema.
B. Procedures. All the subjects wdere examnimmed inl the postabsorptive state. No sedative was given for at least 1 2 hours before the l)erformanicec of the Circulation, Volumte I V, September, 1951 procedure, which was started at approximately 9 a.m.
After two or three 15 minute control periods, 1 to 1.5 mg. of Digoxin in 20 to 30 ml. of 5 per cent dextrose in water were administered intravenously over a 10 minute period. The patients wvere then given to attain adequate blood levels. The sustaining infusion, made up in water, was delivered at 1 ml. per minute. Arterial blood samples were taken as close as possible to the midpoint of each period.
Cardiac catheterization was performed in six of the ten observations in the patients with congestive followed for approximately two hours. Urine was collected with the aid of a multieyed catheter and each collection period was terminated with a bladder wash. The two or three periods immediately after the drug injection were usually 15 minutes and the remainder 20 to 30 minutes in duration.
Eleven normal subjects were given 20 to 30 ml. of 5 per cent glucose in water without Digoxin. Urine collections were obtained over the same length of time as in the Digoxin experiments. In 4 subjects, both of these procedures (control and Digoxin) were done on successive days.
In all cardiac patients and in 4 others, glomerular filtration rate was determined by the inulin and renal plasma flow by the paraaminohippurate (PAH) clearance technics.5 Priming doses of inulin and paraaminohippurate in minimal amounts of water were heart failure.4 The catheter was placed in position before the start of the control periods. Cardiac outputs by the Fick method, central cardiac pressures, femoral arterial and at times femoral venous pressures were determined simultaneously with the renal studies in these 6 patients. In the remaining cardiac patients, femoral or, on occasion, antebrachial venous pressure was determined.
C. Chemical Methods. Sodium and potassium in urine, plasma potassium and serum sodium were determined on an internal standard flame photometer. Chloride in urine and plasma was measured by a modification of the Volhard method.6 Inulin was estimated by Harrison's modification7 of the Alving, Rubin and Miller 
RESULTS
The average sodium excretion in microequivalents (,uEq.) per minute before and one and one-half to two hours after Digoxin in the patients with cardiac edema, noncardiac edema and without edema are shown in figure 1. The intravenous administration of Digoxin caused a prompt sodium diuresis in patients with congestive heart failure. A similar but lesser effect was noted in patients with no cardiac or renal diseases and in those with noncardiac edema. No change in the average sodium excretion occurred among the 11 nonedematous subjects who served as controls and who were given an injection of dextrose without Digoxin. The averages for renal functions and water and electrolyte excretions for the control periods and the periods following the administration of Digoxin in the cardiac group are shown in table 2. The average control value for glomerular filtration rate of 67.6 ml. per minute increased to an average of 75.9 ml. per minute for the first one to two hours after Digoxin. Of the twelve observations that comprise this group, four showed little or no change in filtration rate. An increase in filtration rate of more than 10 ml. per minute following Digoxin was noted in only four of the twelve instances. The group average for renal plasma flow was 176 ml. per minute before and 197 ml. per minute for one and one-half to two hours after _L. EQ The average urine flow in ml. per minute increased from 1.2 to 3.1 in the patients with congestive heart failure. The increases varied from less than 0.5 ml. per minute in 3 patients to approximately 4 ml. per minute in patient 10. Comprising the former group were patient 4 in his fourth and terminal bout of failure, and patients 1 and 7 whose episodes of congestive heart failure were complicated by renal disease and secon(lary anemia respectively. Sodium excretion showed a dramatic increase following Digoxin, the average going from 90 to 254 microequivalents per minute ( fig. 1 , table 2 ). The rather high average control value for sodium excretion was caused by the values obtained in patients 5 and 10 who were having a diuresis on bed rest when the drug was given.
Serum sodium, plasma chloride and plasma potassium concentrations were within normal limits except for patient 8, who had hyponatremia (114 mEq. per liter) and patient 1, who exhibited a mild hyperkalemia (5.8 mEq. per liter).
Femoral venous and right atrial pressures The greatest change occurred in patient 5 whose sodium excretion increased by 624 microequivalents per minute after Digoxin. Again, patients 7 and 4, who had either complications or terminal heart failure, showed the least change.
The rates of chloride excretion paralleled those of sodium in all patients except patient 8. Potassium excretion increased much less, the average being 44 microequivalents per minute before and 67 after Digoxin. decreased in all the cardiac patients after administration of Digoxin (table 2, figs. 3 and 4).
In 5 patients (cases 1, 5, 7, 9 and 10) the control values were below 110 mm. saline. Two of these patients (cases 5 and 9), showed a marked drop to -5 and 0 mm. saline respectively and patient 10 showed a moderate change after Digoxin. Patient The data obtained in pati marized in detail in figure 3. I prompt water, sodium and chlo a sizable decrease in venous prE glomerular filtration rate and ri did not change appreciably, ) excretion increased slightly. ' events was observed in 4 of ti congestive heart failure studie' Figure 4 shows the effect of tient 8 who was in congestive had a hyponatremia of 114 mE Lent 3 are sum-companying his water diuresis following the )igoxin caused a drug, sodium excretion showed little change )ride diuresis and but potassium and chloride excretions increased essure. However, promptly and considerably. These effects began enal plasma flow before changes in glomerular filtration rate and renal plasma flow were observed. Within 45 NDO MINUTES minutes, however, filtration rate and plasma flow increased considerably. B. Effect of Digoxin in Patients with Noti---cardiac Edema. Seven patients with noncardiac edema (5 cirrhotic patients with ascites and 2 patients with nephrotic edema) exhibited an increase in the average sodium excretion from 16 to 39 microequivalents per minute after Digoxin ( fig. 1, table 3 ). This is a small absolute change. However, the control values wCL ere quite low and in each instance sodium ex-NA cretion increased progressively. Concomitantly, chloride excretion rose from 30 to 31 microequivalents per minute while potassium exere--;60 #120 rTs 20 tion did not change. The average urine flow congestive heart showed no appreciable change. Glomerular filtration rate and renal plasma flow were measured during the observations in 3 of the nonedematous subjects given Digoxin. No changes in renal functions or electrolyte excretions were induced by Digoxin in these patients. However, the effects of the infusions of inulin and paraaminohippurate necessary to measure the renal functions may have obscured the rather small effect of Digoxin on electrolyte excretion. kin's disease, and the high initial venous pressure was probably due to partial mediastinal obstruction. In contrast to the above results, the 11 subjects not given Digoxin but otherwise treated in the same fashion ( fig. 1 and table 5 ) showed no significant changes. The mean value for sodium excretion was 102 microequivalents per minute before and 101 after the injection of dextrose without Digoxin. The differences in the values for the control periods and the periods after dextrose were not significant when submitted to statistical analysis. In addition, potassium and chloride excretion and urine flow did not differ before and after the control dextrose injection. D. Effect of Digoxin in Subjects Receiving Desoxycorticosterone Acetate. Three patients free of cardiac or renal disease were given 10 mg. (table 6) . None of these patients had gained weight after one week of therapy. The injection of Digoxin at the end of 1 week of desoxycorticosterone acetate therapy caused a moderate rise in sodium excretion in patient 48 and no change in patient 47. Patient 49 was continued on desoxycorticosterone acetate and her diet was supplemented with 3 to 5 Gm. of sodium chloride a day. At the end of 28 days she had gained 5 pounds and had moderate pitting edema of her feet and pretibial edema. The intravenous administration of Digoxin at this time caused a water and sodium diuresis not unlike that observed in cardiac patients. Potassium and chloride excretions increased considerably. Venous pressure was within normal limits in all 3 patients and fell an average of only 7 mm. of saline following Digoxin. Patient flow is decreased to a greater extent than is the filtration rate, leading to a high filtration fraction. This typical renal function pattern occurred in all patients with congestive heart failure in this study. D)igoxin caused a prompt and considerable water and sodium diuresis in patients with congestive heart failure. This occurred in several patients with little or no change in either glomerular filtration rate or renal plasma, flow. In a fews patients the glomerular filtration rate increased sufficiently after Digoxin to account mathematically for the diuresis. This. however, was not the case in 3 instances and, in any event, the changes in renal hemodynamics following Digoxin were minimal compared with the drug's diuretic effect. The greatest increase in filtration rate after Digoxin occurred in patient 8 ( fig. 4 ), but a brisk diuresis pre- 
DIscussIoN
Though the sequence of events in the production of edema in congestive heart failure is not, known, the ultimate organ responsible for sodium and water retention is the kidney. Likewise, exact knowledge of how the failing heart leads to renal retention of salt and water is subject to debate. Possible factors that might play a role include reduction in glomerular filtration rate resulting in a glomerular-tubular imbalance," increased renal venous pressure,' and hormonal influences."
The renal hemodynamic changes observed in congestive heart failure are well knowVn"2 and include decreased glomerular filtration rate and a reduced renal plasma flow. The renal plasma ceded the first rise in filtration rate. Presumably because of the rather severe hyponatremia in this patient, sodium excretion showed a minimal increase. Chloruresis, however, was considerable and was associated with increased excretion of potassium which apparently took the place of sodium as the main cation in the urine.
The effect of variations in renal venous pressure on electrolyte excretion has been investigated in the (log3 but not in normal man or in patients with congestive heart failure. Based on data obtained in dogs, increased renal venous pressure apparently can lead to water and sodium retention. Thus, it would follow that reduction in venous pressure after Digoxin, which occurred in all but one of the heart failure patients studied, could have contributed to the water and sodium diuresis (table 2) . Whether these phenomena are the result of a direct effect of Digoxin on the veins which reduces renal venous pressure," or whether the observed increase in cardiac output following Digoxin in some way reduces central venous pressure cannot be answered from the present dlata.
That Digoxin may also have a direct action on the renal tubules is suggested by its moderate but definite effect on sodium excretion in patients with noncardiac edema and in nonedematous subjects. In a limited number of observations on nonedematous patients, Digoxin did not alter renal hemodynamics or venous pressure. Other observers have reported that digitalis in normal subjects has little or no effect on venous pressure and that the drug either has no effect on cardiac output or (ecreases it."4
In view of Digoxin's structural similarity to salt-retaining corticosteroids, it may perhaps compete with some desoxycorticosterone-like hormone acting on renal tubule cells. Indeed, evidence has been obtained in rabbits that is compatible with this hypothesis."
Preliminary studies reported in this paper indicate that Digoxin may have a greater action in subjects treated with desoxycorticosterone acetate to the point of salt retention than in the untreated normal subject.
SUMMARY
Digoxin causes a prompt ancl considerable water and salt diuresis in patients with congestive heart failure. This may occur with little or no change in renal hemodynamics, but usually is associated with decreased venous pressure. At times, increased glomerular filtration rate may contribute to the diuresis. In patients with noncardiac edema and without edema, Digoxin may also initiate a slight but definite sodium diuresis. This effect is not as great as in patients faith congestive heart failure and apparently is not associated with changes in renal hemodynamics, cardiac output or venous pressure. Thus, D)igoxin may act by virtue of an effect on the renal tubule cells, perhaps by competing with some desoxycorticosterone-like hormones, by reducing renal venous pressure, and at times, by increasing glomerular filtration rate. The diuretic effect may also be related in some unknown fashion to improved cardiac function.
